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Abstract
Mammalian cells possess a cell-autonomous molecular clock which controls the timing of many
biochemical reactions and hence the cellular response to environmental stimuli including genotoxic
stress. The clock consists of an autoregulatory transcription-translation feedback loop made up of
four genes/proteins, BMal1, Clock, Cryptochrome, and Period. The circadian clock has an intrinsic
period of about 24 hours, and it dictates the rates of many biochemical reactions as a function of the
time of the day. Recently, it has become apparent that the circadian clock plays an important role in
determining the strengths of cellular responses to DNA damage including repair, checkpoints, and
apoptosis. These new insights are expected to guide development of novel mechanism-based
chemotherapeutic regimens.
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Introduction
The circadian clock and the DNA damage response are two global regulatory mechanisms that
control many aspects of cellular physiology and adaptation to the environment at the cellular
and organismal level. The two regulatory systems can operate independently of one another.
However, under physiological conditions, the two systems interface. As a consequence, a signal
that primarily affects one system, to varying degrees, ultimately affects the other as well. In
this review we will mainly focus on our current understanding of the control of the DNA
damage response by the circadian clock. The DNA damage response includes DNA repair,
DNA damage checkpoints, apoptosis, and transcriptional reprogramming, and current evidence
indicates that all these responses are gated by the circadian clock (Figure 1). In the following,
the basic molecular mechanism of the mammalian clock will be described first, followed by a
survey of recent findings on the control of the DNA damage response by the clock, and how
these findings may be used to develop new chemotherapy regimens. Finally, we discuss the
possible evolutionary link between the circadian clock and the cellular response to DNA
damage.
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The circadian clock is the molecular system that confers daily rhythmicity to physiologic
functions [1-4]. The clock is cell-autonomous and self-sustaining; that is, it keeps time in the
absence of external input. However, in mammalian organisms the cell-autonomous clocks in
the peripheral organs such as liver, heart, kidney, and skin are synchronized with one another
by neural and humoral inputs from the “master clock” in the brain [1]. The master clock is
located in the suprachiasmatic nucleus (SCN) which is in the anterior hypothalamus in two
clusters of neurons above the optic chiasma. The basic molecular architecture of the SCN clock
is the same as those of the peripheral clocks; however, the SCN has the capability of signaling
to, and thus synchronizing, the peripheral clocks with itself and with one another.
At the molecular level the clock is made up of 4 genes/proteins: Clock, BMal1, Crys
(Cryptochrome 1 and 2), and Pers (Period 1 and 2) which operate in the following manner to
generate a transcription-translation feedback loop (TTFL) (Figure 2): Clock and BMal1 are
bHLH-PAS domain-containing transcriptional activators which make a heterodimer that binds
to the E-boxes (CACGTG) in the promoters of the Cry and Per genes and activate their
transcription. The Cry and Per proteins, in turn, make heterodimers or higher order multimeric
complexes which, after a time lag, enter the nucleus and inhibit Clock-BMal1-activated
transcription. Clock-BMal1 also controls the transcription of about 10% of the genes in a given
cell, causing rhythmic expression of these so-called clock-controlled genes (CCG) [5]. In
contrast to Crys and Pers, the proteins encoded by CCGs do not seem to directly feed back into
the clock TTFL. However, the core clock circuitry is consolidated by additional transcriptional
circuits as well as post-translational modifications that ensure high amplitude and a high-
precision clock.
Clock Control of DNA Repair
DNA repair is the ensemble of enzyme systems that eliminates DNA damage which might be
defined as covalent change in the DNA structure [6]. There are several DNA repair
mechanisms, including direct repair (photolyases and alkyl transferases), base excision repair
(glycosylases and AP endonucleases), nucleotide excision repair, and double-strand break/
crosslink repair. Currently available evidence indicates that of these repair mechanisms, only
nucleotide excision repair is tightly controlled by the circadian clock. Hence, the mechanism
of nucleotide excision repair and the control of this repair pathway by the circadian clock will
be discussed in some detail.
(1) Nucleotide Excision Repair
Nucleotide excision repair (excision repair) is a universal repair system that acts on virtually
all types of base lesions. In many organisms, including humans and mice, it is the only repair
system for bulky DNA adducts such as UV-induced cyclobutane pyrimidine dimers
(Pyr<>Pyr) and cisplatin induced cisplatin-1,2-d(GpG) diadducts. In humans, excision repair
is carried out by 6 factors [7-10]: RPA, XPA, XPC-HR23, TFIIH, XPG, and XPF-ERCC1,
and proceeds as follows (Figure 3): RPA, XPA, and XPC, acting cooperatively, bind to the
damage site and recruit TFIIH through its interactions with XPA and XPC. The two helicases
within the TFIIH complex (XPB and XPD) unwind the DNA by about 20 bp around the damage
to form a stable complex called pre-incision complex 1 (PIC1). Then, XPG enters the assembly
as XPC-HR23 exits, to form PIC2. Finally, XPF-ERCC1 is recruited through a strong
interaction with XPA to form PIC3. At each of these steps ATP is hydrolyzed, and the free
energy of ATP hydrolysis is used to unwind the helix as well as to amplify the damage
recognition specificity of the enzyme system by “kinetic proofreading” [9]. Within PIC3, XPG
makes the 3′ incision 6±3 nucleotides 3′ to the lesion and XPF makes the 5′ incision 20±5
nucleotides 5′ to the damage [10]. The resulting 24-32 nucleotide-long oligomer carrying the
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lesion is released along with the repair factors, except RPA. The RPA-bound excision gap
recruits RFC clamp loader and PCNA clamp, and eventually DNA polymerases δ/ε which fill
the excision gap, and the repair patch is ligated by DNA ligase I.
Mutations in excision repair proteins XPA, XPB, XPC, XPD, XPF, and XPG cause xeroderma
pigmentosum. This disease is characterized by extreme sensitivity to sunlight, ~10,000-fold
increase in the incidence of skin cancer, and, in some of the complementation groups, by mental
and developmental abnormalities [7,8]. In addition to the core excision repair factors essential
for dual incision/excision, an accessory protein, DDB2, which is encoded by the XPE gene and
is in a complex with a ubiquitin E3-ligase called DDB1 (UV-DDB=DDB1-DDB2=UV-
damaged DNA binding protein), prevents UV carcinogenesis by an unknown mechanism
[11]. Finally, in a form of XP called XP variant (XPV), a mutation in the XPV gene which
encodes DNA polymerase η leads to high error-prone translesion synthesis by other
polymerases across UV-photoproducts resulting in a high rate of mutation and cancer [12].
(2) Regulation of Nucleotide Excision Repair
Among the XP proteins, the regulation of XPE (DDB2), XPC-HR23, and XPA have been
studied in some detail. The XPE gene is induced after DNA damage in a p53-dependent manner
[13-15]. Then, the induced protein is ubiquitinated by the RING-type CUL4a-Roc1-DDB1 E3
ligase and degraded by the proteasome [16]. Similarly, XPC transcription is induced by DNA
damage including UV-induced damage [14,15]. However, in contrast to DDB2, this
transcriptional induction does not result in elevated levels of XPC protein after DNA damage
[17-19]. Like DDB2, XPC is ubiquitinated by CUL4a-Roc1-DDB1 following DNA damage,
but unlike DDB2, ubiquitinated XPC is not targeted for proteolytic degradation by the
proteasome [17,18]. Currently, the physiological relevance of DDB2 ubiquitination and
degradation, and of XPC ubiquitination, but not proteasomal degradation, are not known
[20-22]. In contrast, XPA is ubiquitinated independently of DNA damage, and the
ubiquitinated protein is targeted for proteolytic degradation [23,24]. The regulation of
mammalian excision repair by XPA ubiquitination and proteolysis is discussed in more detail
below.
(3) Regulation of Nucleotide Excision Repair by the Circadian Clock
Analysis of nucleotide excision repair activity over the course of a day in various mouse tissues
revealed that the repair activity has a robust circadian rhythm in brain [23] and liver but not in
testis [24] (Figure 4A). Of the 6 core excision repair factors, only the XPA protein oscillates,
and this oscillation is in phase with the excision repair activity and anti-phase with the Cry1
protein which functions as a transcriptional repressor in the core clock mechanism [23]. Further
analysis revealed that Xpa is a clock-controlled gene that contains two canonical E-boxes in
its promoter. Accordingly, in Cry1-/-Cry2-/- mice, Xpa transcription and XPA protein levels
are constitutively high and no longer rhythmic [24]. However, robust transcriptional rhythm
is not necessarily sufficient for rhythmic protein levels. If the rhythmically transcribed protein
is stable, the transcriptional rhythm might confer protein level rhythmicity of only modest
amplitude. However, if the rhythmically transcribed protein is targeted by the ubiquitin-
proteasome system for ubiquitination and subsequent degradation by proteolysis, then high
amplitude protein oscillation can be achieved. In fact, all core clock proteins that exhibit
rhythmicity, Cry1 and Cry2 [25,26], Per1 and Per2 [27,28], and BMal1 [29], are targeted by
specific E3 ubiquitin/SUMO ligases for ubiquitination or sumoylation and subsequent
degradation by the proteasome. As a consequence, all of these proteins have half-lives of ~3
hrs. To find out if proteolytic degradation to achieve rhythmicity applied to a clock output
protein, the half-life of XPA was measured and it was found that XPA also has a half-life of
~3 hrs [24].
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Further analysis revealed that XPA is ubiquitinated by a HECT family E3 ligase called HERC2
[24]. Downregulation of HERC2 stabilizes XPA (Figure 4B) and increases cellular repair
capacity moderately [24]. Similarly, in Cry1-/-Cry2-/- cells, XPA levels and excision repair
activity are elevated. Interestingly, HERC2 itself is a clock-controlled protein that oscillates
in-phase with XPA in liver, but it does not oscillate in the brain (T.H.K. and A.S., unpublished
data), even though Xpa transcription and XPA protein levels oscillate in both organs. Thus, it
appears that a protein such as XPA that is made in a rhythmic manner may exhibit an oscillatory
pattern of accumulation whether it is degraded at a constant rate or in an oscillatory manner.
In addition to XPA and excision repair, it has been reported that O6-methylguanine-DNA
methyl transferase [30] and alkylguanine DNA glycosylase [31] also exhibit circadian
oscillation. However, the ratio of the nadir to the zenith for these enzymes is only about 1.2-
fold (as opposed to 5- to 10-fold for XPA), and therefore the physiological significance of those
oscillations is unclear at present.
Clock Control of DNA Damage Checkpoints
DNA damage checkpoints are cellular surveillance mechanisms that slow down or arrest cell
cycle progression in response to DNA damage [6]. In mammalian cells, two checkpoint
signaling pathways have been described: the ATR Chk1 pathway that is activated by UV, UV-
mimetic agents, and chemical agents that inhibit replication fork progression, and the
ATM→Chk2 pathway which is mainly activated by double strand breaks that are induced by
ionizing radiation and radiomimetic agents (Figure 5). Both pathways encompass damage
sensors, mediators, signal transducers, and effectors. The damage is detected by the ATR and
ATM sensor kinases with the aid of accessory proteins, and is transmitted to signal transducing
kinases, Chk1 and Chk2, with the aid of mediators. Signal transducing kinases then
phosphorylate effector proteins including p53, Cdc25, and Cdc45. Phosphorylation of these
proteins eventually leads to inhibition of two key kinases, Cdc2 and Cdk2, which cause cell
cycle arrest at G2/M and G1/S, respectively. In addition to halting cell cycle progression, the
DNA damage checkpoint response activates some DNA repair pathways that rescue stalled
replication forks and repair double-strand breaks. The circadian clock affects the DNA damage
checkpoint response in two ways: at the transcriptional level by controlling the transcription
of the checkpoint proteins and by direct participation of the clock proteins in the checkpoint
response. Accordingly, two mechanisms of circadian clock-DNA damage checkpoint
connection have been described, serial and direct connections [32] (Figure 6).
(1) Serial connection of the circadian clock to the cell cycle checkpoints
In this model of coupling of the clock to the cell cycle checkpoints, the core clock system
regulates genes that are involved in generating checkpoint signals, in sensing these signals,
and in transducing the signals and executing the cell cycle arrest (Figure 6A). Examples for
each of these are discussed below.
First, regulation of nucleotide excision repair by the clock [23,24] results in generation of
single-stranded DNA in the form of excision gaps in a rhythmic manner. Single-stranded DNA
is a universal signal for ATR-mediated checkpoint signaling [6]. In non-dividing cells exposed
to UV or UV-mimetic agents such as cisplatin, nucleotide excision repair is solely responsible
for generating single-stranded DNA in the form of 24-32 nt-long excision gaps. Although
unprocessed damage itself and RNA polymerases stalled at damage sites are capable of
initiating checkpoint signaling [6,33], it is most likely that in non-dividing cells at all times,
and even in proliferating cells in G1 and G2 phases of the cell cycle, the excision gaps are the
strongest signal for ATR activation. Because the XPA protein, and therefore excision repair
activity, exhibits robust circadian rhythmicity, it is expected that UV-induced checkpoint
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signaling in such cells would manifest similar rhythmicity. However, this deductive prediction
awaits experimental verification.
Second, the c-myc oncogene, which plays a key role in cellular proliferation as a bHLH
transcription factor regulating a number of genes critical for G1/S transition, is a first-order
clock controlled gene [34]. The mouse c-myc gene contains a canonical E-box in its promoter
to which BMal1-NPas2(Clock) bind and inhibit c-myc transcription. In Per2 mutant mice, c-
Myc is elevated because Per2 positively regulates BMal1 transcription; and in the absence of
Per2, the BMal1-NPas2 level is reduced causing overexpression of c-Myc and promotion of
cellular proliferation. Indeed, it has been reported that in Per2 mutant mice the overexpression
of c-Myc is a major contributor to high-incidence of IR-induced lymphomas [34].
Third, the p21 gene is a second-order clock controlled gene which is negatively regulated by
Rev-Erbα, which in turn is positively regulated by Clock-BMal1 [35]. Upon DNA damage the
transcription of p21 is induced, and the elevated p21 protein level plays a critical role in the
maintenance of G1/S checkpoint by binding to Cdk2 and inhibiting its activity. Furthermore,
p21 binds to PCNA, inhibits DNA replication, and thus participates in intra-S checkpoint.
Because of these important functions, it appears that in BMal1 mutant mice, reduced Rev-
Erbα activity and hence elevation of p21 causes the mutant cells to exhibit a delay in the G1/
S transition [35].
Finally, the Wee1 gene, which plays a key role in mitosis, is a first-order clock-controlled gene
[36]. The Wee1 kinase phosphorylates the mitotic cyclin-dependent kinase, Cdc2, causing its
inactivation and preventing the G2/M transition. In Cry mutant mice, Wee1 is elevated in the
liver, and as a consequence, after partial hepatectomy, even though the wild-type and mutant
hepatocytes reportedly progress through the G1 and S phases of the cell cycle similarly, the
Cry mutants are delayed in entering mitosis resulting in slower regeneration of the liver [36].
However, despite this effect on normal hepatocyte progression through the cell cycle, it appears
that elevated Wee1 does not affect the G2/M checkpoint significantly: Cry1-/-Cry2-/- mouse
fibroblasts which overexpress Wee1 exhibit growth properties and G2/M checkpoint response
to IR or UV indistinguishable from wild-type animals; they do not have prolonged arrest at the
G2/M boundary and recover from the damage induced G2/M arrest essentially at the same rate
as wild-type cells [37]. It is thus likely that the consequences of elevated Wee1 levels could
be context-dependent and modulated by cellular physiology, cell-type, and the cellular
environment.
(2) Direct connection of the circadian clock to the DNA damage checkpoints
In this mode of clock control of the checkpoint response, one or more proteins in the core clock
circuitry also participate in DNA damage checkpoints. Currently, two examples for this mode
of coupling are known (Figure 6B).
In one case, the Timeless (Tim) protein couples the clock to the ATR→Chk1 signaling pathway
[32]. Tim is an accessory clock protein [1-3] that consolidates the core clock circuitry in
mammalian organisms: Through its direct interaction with cryptochrome it participates in the
molecular clock. Similarly, Tim participates in ATR→Chk1 signaling through its direct
interaction with both ATR and Chk1 [32]. As a consequence, down-regulation of Tim disrupts
both the circadian clock and the ATR→Chk1 DNA damage signaling pathway.
Downregulating Tim in SCN slices drastically alters the levels of Crys and Pers and abolishes
the oscillatory pattern of the SCN electrochemical output indicating that Tim is a bona fide
clock protein in mammals [38]. However, Tim knockout in mice causes embryonic lethality
[1], and therefore, it has not been possible to investigate the effect of Tim mutation on
behavioral rhythmicity because of its essential function. Essential functions for Tim likely
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include its role in sister chromatid cohesion and its role in both intra-S and replication
checkpoints [32].
In the second example of direct coupling of the clock to the DNA damage checkpoints, Per1
participates both in the core clock machinery and in the ATM→Chk2 DNA damage signaling
pathway [39]. The role of Per1 in the circadian clock as a co-repressor is well-understood
[1-3]. It participates in the negative arm of the autoregulatory transcription-translation loop.
Per1-/- mice have long periods and are prone to become arrhythmic in constant darkness. In
its role in the DNA damage checkpoints, Per1 participates in ATM→Chk2 signaling by directly
interacting with both ATM and Chk2. Downregulation of Per1 interferes with phosphorylation
of Chk2 by ATM after IR treatment and reduces DNA damage-induced apoptosis. Conversely,
overexpression of Per1 inhibits proliferation of a number of cancer cell lines by promoting
apoptosis [39]. In agreement with the cell biological data, it has been reported that Per1 is
downregulated in a number of cancers, including lung and breast cancers [39].
Clock Control of Apoptosis
Apoptosis is programmed cell death that has important physiologic and pathologic
consequences [40]. From a physiologic perspective, apoptosis plays an essential role during
development in sculpting organs during embryogenesis. From a pathologic standpoint, it is an
important contributor to cell death in several pathologic conditions such as tissue damage in
cardiovascular and cerebrovascular ischemia by initiating extensive cell death in response to
reactive oxygen species (ROS) generated by transient ischemia [40]. Finally, one of the most
significant advances in cancer biology in recent years has been the realization of the importance
of apoptosis in preventing oncogenically transformed cells from proliferation and hence from
producing overt cancer. It appears that, as a rule, oncogenically transformed cells are more
prone to apoptosis than normal cells [41].
Formally, two biochemical pathways of apoptosis have been defined [40], extrinsic and
intrinsic pathways (Figure 7A). In the mitochondria-independent, extrinsic (death receptor)
pathway, a member of the tumor necrosis factor family, such as TNFα, binds to its cognate
death receptor in the plasma membrane causing clustering of the receptor and the cytoplasmic
adaptor molecules, and as a consequence, dimerization of pro-caspase 8. The latter is activated
by autoproteolysis in trans to generate initiator caspase 8, which in turn converts pro-caspase
3 to the executioner caspase 3 that dismantles cellular architecture, destroys some key cellular
enzymes, and activates caspase activated DNase (CAD) which attacks chromosomes,
generating the apoptosis signature feature, the “nucleosome ladder” [42]. Recent work
indicates that the core circadian clock participates in the extrinsic pathway by regulating the
synthesis of TNFα [43]. Moreover, as TNFα is known to be involved in the inflammatory
response, Cry1-/-Cry2-/- mice which overexpress TNFα are uniquely sensitive to inflammatory
stimuli and exhibit a rheumatoid arthritis-like syndrome caused by such stimuli [44].
In the intrinsic (or mitochondrial) pathway, cellular damage, including DNA damage and stress
caused by unfolded proteins, leads to increased expression of pro-apoptotic members (Bax and
Bak) of the Bcl-2 family. The p53 tumor suppressor plays an important role in DNA damage-
initiated intrinsic apoptosis pathway [41]. Indeed, it appears that p53 acts a tumor suppressor
to a large extent by inducing apoptosis in oncogenically transformed cells by upregulating the
expression of pro-apoptotic Bax and Bak in response to genotoxic stress (Figure 7A). With
respect to clock-intrinsic apoptosis pathway, there appears to be a direct connection between
the core clock and p53: BMal1 upregulates [45] and Cry downregulates [46] p53 expression,
even though p53 does not have a robust circadian rhythm because of multiple other inputs into
the regulation of this multipurpose tumor suppressor. In addition, in a cell-based assay,
knockdown of p53 reduces the amplitude of the circadian rhythm [47], but p53 mutant mice
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have an apparently normal clock. Clearly, the clock-p53-apoptosis connection is rather
complex. Of special significance, p53-/-Cry1-/-Cry2-/- fibroblasts are more sensitive to
genotoxicant-induced apoptosis than p53-/- cells (Figure 7B) [46], suggesting that Crys
negatively regulate a p53-independent apoptotic pathway that becomes more relevant in a
p53-/- background.
Clock, Cancer, and Chemotherapy
The interfacing of the clock at multiple points with cellular responses to DNA damage leads
to the inevitable prediction that circadian clock disruption may contribute to carcinogenesis
and that the clock would play significant roles in cancers induced by genotoxicants as well as
in treating cancers by DNA damaging agents. Indeed, such connections do exist and these
topics have been the subject of several recent reviews [48-56] and will be discussed here briefly.
(1) Circadian Clock and Cancer
Based largely on epidemiologic data, it was widely believed that circadian clock disruption
predisposes humans to cancer [48,49]. A study with Per2 mutant mice seemed to support this
view [34]. It was reported that after IR treatment these mice developed lymphomas at about
10-fold higher incidence than wild-type mice. The higher incidence of lymphoma was ascribed
to upregulation of c-myc oncogene and downregulation of p53 tumor suppressor, and hence
reduced apoptosis of transformed cells in the mutant mice [34,48]. However, studies with
Cry mutant mice revealed a more complex pattern of interactions among the clock, apoptosis,
and oncogenic transformation. First, Cry1-/-Cry2-/- mice, which lack a circadian clock, are
indistinguishable from wild-type mice with respect to the incidence of both spontaneous and
IR-induced cancers [37]. Second, when the Cry mutation was combined with the p53 mutation,
with the expectation that clock disruption would increase cancer incidence in mice already
predisposed to cancer because of the p53 mutation, a paradoxical result was obtained [46]: The
Cry mutation protected p53 mutant mice from early onset of cancer and extended their median
lifespan by ~50% from 19 weeks to 28 weeks (Figure 7C).
To explain this unexpected finding, immortal cell lines of p53-/- and p53-/-Cry1-/-Cry2-/-
genotypes were analyzed for the integrity of the DNA damage response pathways that
contribute to cancer prevention, including DNA repair, DNA damage checkpoints, and
apoptosis. The two cell lines behaved similarly with respect to repair of UV-induced DNA
damage and UV-induced activation of ATR→Chk1 and ATM→Chk2 signaling pathways
[46]. In contrast, as noted above, it was found that elimination of Cry in immortal p53-deficient
cells made the cells more sensitive to killing by apoptosis by genotoxic agents including UV
(Figure 7B). Therefore, it was proposed that the increased sensitivity to apoptosis by endo-
toxicants might be the mechanism by which the Cry mutation in p53 mutant mice prevented
oncogenically transformed cells from proliferating to overt cancers. The mechanism by which
the Cry mutation activates the p53-independent apoptosis pathway remains to be elucidated.
Finally, studies with Clock or BMal1 mutant mice have reinforced the notion that clock
disruption in itself does not predispose animals to cancer. Thus, even though Clock mutants
are more sensitive than wild-type to acute lethal effects of cyclophosphamide, presumably
because of increased toxicity to B lymphocytes [57], the mutants were indistinguishable from
wild-type with respect to the incidence of spontaneous and IR-induced cancers [58]. Similarly,
BMal1 mutants do not exhibit increased rates of cancers; however, these mice exhibit a
premature aging phenotype, presumably because of increased rate of ROS production [59] and
chronic oxidative stress.
To summarize, the hypothesis that clock disruption predisposes animals to cancer, as a general
rule, has not been supported by experimental tests. A more conservative view that clock
Sancar et al. Page 7













disruption by certain mechanisms (such as Per mutations) or by unorthodox lifestyles may
promote cancer is plausible and it deserves further critical investigations.
(2) Circadian Clock and Chemotherapy
Chronochemotherapy is the administration of anticancer drugs at specific times of the day so
as to achieve optimal outcomes with tolerable side effects [51-56]. The effect of genotoxic
chemotherapeutic drugs such as cisplatin on cancer cells is dictated, in addition to
pharmacokinetic and pharmacodynamic factors, by cellular response to DNA damage
including DNA repair, DNA damage checkpoints, and apoptosis. Because these responses are,
to varying degrees, controlled by the clock it is to be expected that the time of drug delivery
would affect its efficacy. Indeed, some small scale clinical trials have reported dramatic effects
of chronochemotherapy [51]. However, as a rule, the effects of chronotherapy in large scale
trials have been modest [56], and as a consequence chronotherapy is not currently practiced
by oncologists. This is, in part, due to the empirical nature of the past clinical trials. The recent
advances in understanding the mechanistic links between the clock and the DNA damage
response summarized here are expected to lead to mechanism-based chronotherapy regimens
in the near future. In fact, the high amplitude circadian oscillation of excision repair has led to
the proposal of the following specific cisplatin chronotherapy schedule in a mouse model.
In all organs tested in mouse, with the exception of testis [24], excision repair of cisplatin
adducts is at its zenith at ~5 pm and its nadir at ~5 am [24]. Therefore, a cisplatin treatment
regimen that would maximize cisplatin-DNA adduct formation at ~5 am should be most
effective against mouse cancers responsive to cisplatin. Moreover, it has been found that after
intra-peritoneal injection of a single cisplatin dose, the cisplatin-DNA adduct level reaches its
maximum in about 1 hr in mouse liver and likely other major organs except the brain [60].
Thus, ignoring other factors that might influence the cytotoxicity of the drug, it would appear
that ~5 am would be the best time to treat cancer with cisplatin in mice. Because circadian gene
expression and circadian physiology of humans are out of phase with those of nocturnal mice
by 12 hr [52], administering cisplatin at ~5 pm might be optimal or treatment of human cancers
except testicular cancer. Indeed, there are reports of higher success rate in treating ovarian
cancer with cisplatin when the drug is delivered at 6 pm compared to 6 am [61,62]. However,
these reports have not been confirmed in subsequent studies [52], underscoring the need for
mechanism-based approaches. Clearly, chemotherapeutic regiments that take into
consideration the circadian phases of both the cancer and the normal tissue are needed to further
refine chronotherapy and make it a standard part in the cancer treatment arsenal.
Concluding Remarks
According to the “Escape from Light” hypothesis for the evolution of the circadian clock
[63], an ancient aquatic organism employed a blue-light sensor (because blue light penetrates
the deepest in water) to synchronize its movements to and from the surface of the ocean so as
to optimize nutrient availability and minimize exposure to the harmful effect of the UV
component of sunlight. It is conceivable that the last common ancestor of the present day
photolyase/cryptochrome family was the blue light sensor directing the diel vertical movement
as well as using the blue light as an energy source to repair the UV-induced DNA damage that
occurred under those conditions [64,65]. This primitive flavoprotein with blue-light absorption
maxima then diverged to give rise to the present day photolyases which repair DNA and to
cryptochromes that control the circadian clock by light-dependent and light-independent
mechanisms [64,65].
Thus, even though the possible common evolutionary origin of the circadian clock and the
mechanisms to maintain genomic integrity were recognized early-on in the circadian research
fields [63], only recently have the multiple links between the two systems been described. It
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should be noted, however, that even though photolyase no longer has a photosensory function
and cryptochrome no longer has a direct DNA repair function, cryptochrome still participates
in the maintenance of genomic integrity against DNA damage induced by UV and UV-mimetic
agents [24,66]. Cryptochrome contributes to DNA repair/genome maintenance by regulating
nucleotide excision repair which is the sole repair mechanism for repairing UV-induced
photodimers in placental mammals which lack photolyase [65], and by coordinating the
circadian clock with DNA damage checkpoints which also aids in cell survival and hence in
“escape from light” [63,65].
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ROS reactive oxygen species
CAD caspase activated DNase
EST Eastern Standard Time
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Circadian gating of DNA damage responses. Major cellular response pathways to DNA
damage including DNA repair, DNA damage checkpoints, apoptosis, and transcriptional
reprogramming are gated by the circadian clock.
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Mammalian molecular clock. The bHLH-PAS domain-containing proteins Clock and BMal1
make a heterodimer which bind to the E-boxes (CACGTG) in the promoters of the Per and
Cry genes, as well as in the promoters of the clock controlled genes, such as the excision repair
gene Xpa and the checkpoint gene Wee1, activating their transcription. The Cry and Per proteins
dimerize and, after a time lag, enter the nucleus and inhibit Clock-BMal1-activated
transcription of their own genes as well as of those of clock-controlled genes, thus generating
an oscillatory pattern of gene expression. Modified from [67].
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Model for nucleotide excision repair in humans and its regulation by the circadian clock.
Excision of DNA damage is accomplished by sequential and partially overlapping functions
of 6 core repair factors. Damage is recognized by cooperative activities of RPA, XPA, and
XPC, followed by recruitment of TFIIH by XPC and XPA. The DNA around the damage site
is unwound by the helicase activity of TFIIH to form a stable pre-incision complex 1 (PIC1)
which recruits XPG, and XPC is displaced from the complex to form PIC2. Then XPF-ERCC1
is recruited to form PIC3. Within PIC3, XPG makes the 3′ incision 6±3 phosphodiester bonds
3′ and XPF makes the 5′ incision 20±5 phosphodiester bonds 5′ to the damage. The excised
24-32 nucleotide-long oligomer carrying the damage is released and the resulting gap is filled
by DNA polymerases and ligated. The XPA protein which plays an essential role in damage
recognition and is a rate-limiting factor is regulated by the clock, and as a consequence the
daily oscillation of XPA (sinusoidal arrow) causes the entire excision repair activity to exhibit
a daily rhythm, increasing during the day and decreasing during the night. Modified from [9,
66].
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Circadian regulation of XPA and excision repair by the clock and the ubiquitin-proteasome
system in the liver but not in testis. (A) Circadian rhythm of XPA transcript, protein, and
nucleotide excision repair in mouse liver (left panel) but not testis (right panel) (ZT=0 is light
on and ZT=12 is light off; EST=Eastern Standard Time) [23]. (B) HERC2 E3 ligase controls
XPA stability. A549 cells were transfected with either cyclophilin-B siRNA (control) or
HERC2 siRNA and then incubated with cycloheximide (CHX, a protein synthesis inhibitor)
for the indicated times and the XPA protein levels were determined by immunoblotting [24].
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DNA damage checkpoint pathways. The pathways encompass damage sensors, mediators,
signal transducers, and effectors. DNA damage in the form of double-strand breaks induced
by ionizing radiation or radiomimetic agents activates the ATM→Chk2 pathway. DNA
damage by UV and UV-mimetic agents activates the ATR→Chk1 pathway. Modified from
[6].
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Two models for coupling the circadian clock to the cell cycle/checkpoint response. (A) Serial
coupling. The XPA repair factor, the p21 and Wee1 cell cycle proteins, and the c-Myc
transcription factor, which are involved in DNA repair, the cell cycle, and cellular proliferation,
respectively, are encoded by clock-controlled genes (CCG), and hence DNA repair, checkpoint
activation, cell cycle regulation, and cellular proliferation are gated by the clock (solid line).
Conversely, the cell cycle influences the circadian cycle by halting transcription during mitosis,
thus causing a phase shift of the circadian rhythm (broken line). (B) Direct coupling. The core
circadian clock protein Cry, in conjunction with Tim participates in the ATR-Chk1 signaling
pathway in response to UV and UV-mimetic agents. Similarly, Per1 participates in the ATM-
Chk2 signaling pathway in response to IR and radiomimetic agents.
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Regulation of apoptosis by the circadian clock. (A) The extrinsic and intrinsic apoptosis
pathways. Circadian regulation of the extrinsic pathway occurs by regulating the synthesis of
TNFα which binds to death receptors, which through death adaptors transduce the signal to
caspase 8 which in turn activates executioner caspases including caspase 3. In the intrinsic
pathway, DNA damage activates p53 (in a circadian regulated manner) which activates
transcription of Bax and Bak pro-apoptotic members of Bcl2 family. Bax and Bak cause release
of cytochrome c (c) from mitochondrial intermembrane space. Cytochrome c helps assemble
Apaf1 into an apoptosome which leads to cleavage and activation of transducer caspase 9 which
in turn cleaves and activates executioner caspase 3. (B) Elimination of Crys in immortal p53-
deficient cells makes cells more sensitive to killing by apoptosis induced by genotoxic agents
including UV [46]. (C) Cry mutations increase the life-span of p53-/- mice [46]. The Kaplan-
Meier survival analysis of mice of the indicated genotype is shown. Significant differences
were observed between p53–/– (n=35) and p53–/–Cry1–/–Cry2–/– (n=19) mice (P < 0.0001).
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